| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$191 |
FY24 Results Market Release
|
29 Aug 2024 10:08AM |
$0.260 |
$0.420 |
risen by
61.54%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker achieved positive free cash flow of $1.2 million in FY24, an improvement of $8.9 million from the previous comparative period (pcp).
- Airtasker marketplaces' revenue grew by 9.8% to $38.1 million.
- The UK marketplace saw a substantial revenue growth of 76.3% in 4Q24.
- As of 30 June 2024, Airtasker had $17.8 million in cash and term deposits.
- Airtasker secured $11.0 million in Australian advertising inventory from oOh!media and ARN Media.
- Employee expenses were reduced by 26.1% to $22.4 million.
- Technology, general, and administrative expenses decreased by 16.4% to $10.7 million.
- EBITDA improved by 97.8% to a loss of $0.2 million.
- Completed tasks reached a record number due to improved marketplace reliability and a decline of 26.3% in cancellations.
- Airtasker’s Australian marketplaces generated $31.0 million EBITDA, enabling investment in new marketplaces.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$98 |
Generative AI Company Acquisition Presentation
|
29 Aug 2024 10:06AM |
$0.013 |
$0.054 |
risen by
315.38%
|
|
VR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Vection Technologies is acquiring The Digital Box to enhance AI capabilities.
- The acquisition aims to improve human-machine interactions across various sectors using AI.
- The combined portfolio will include hardware, software, VR, and AR solutions.
- The Digital Box specializes in AI avatars and has strong integrations with OpenAI.
- The acquisition will add approximately $10m in revenue and $1m in EBITDA for Vection.
- Former Apple COO Marco Landi will join Vection’s board.
- The acquisition aims to capitalize on opportunities in healthcare, retail, space economy, gaming, and real estate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Capital Limited (WAM) ORDINARY FULLY PAID |
Financials |
$1,937 |
Appendix 4E and Annual Report
|
29 Aug 2024 10:06AM |
$1.540 |
$1.720 |
risen by
11.69%
|
|
WAM - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Capital Limited's financial position and performance for the year ended June 30, 2024 is detailed.
- The audit was conducted in accordance with Australian Auditing Standards and the company complied with relevant ethical requirements.
- Key audit matters include the existence and valuation of financial assets and the accuracy of management and performance fees.
- The company’s investments are based on observable data from the ASX and other markets.
- Control and valuation processes were evaluated and confirmed by the audit.
- The remuneration report for WAM Capital Limited for the year ended June 30, 2024 complies with the Corporations Act 2001.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Civmec Limited (CVL) ORDINARY FULLY PAID |
Industrials |
$610 |
Update on Approval Application
|
29 Aug 2024 10:06AM |
$1.090 |
$1.200 |
risen by
10.09%
|
|
| Saunders International Limited (SND) ORDINARY FULLY PAID |
Industrials |
$105 |
Resignation of Company Secretary
|
29 Aug 2024 10:05AM |
$0.820 |
$0.810 |
fallen by
1.22%
|
|
| Raiz Invest Limited (RZI) ORDINARY FULLY PAID |
Financials |
$66 |
Application for quotation of securities - RZI
|
29 Aug 2024 10:05AM |
$0.390 |
$0.630 |
risen by
61.54%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$191 |
FY24 Full Year Statutory Accounts
|
29 Aug 2024 10:05AM |
$0.260 |
$0.420 |
risen by
61.54%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker Limited has issued ordinary shares amounting to 452,498,074 fully paid shares as of 30 June 2024.
- Unclaimed customer credits amounted to $2,894,000 for FY24, down from $4,607,000 in the previous year.
- Various shares under rights and options were issued throughout the year, with detailed movements and issue dates listed.
- The company's revenue recognition policy for unclaimed customer credits includes customer redemption or expiration, with an 18-month expected realization period.
- The directors' report and notes to the consolidated financial statements include detailed financial data and explanations for the year ended 30 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
Investor Webinar Information - FY24 Results
|
29 Aug 2024 10:03AM |
$0.060 |
$0.015 |
fallen by
75%
|
|
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$5 |
Appendix 4G & Corporate Governance Statement
|
29 Aug 2024 10:03AM |
$0.096 |
$0.069 |
fallen by
28.13%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$2 |
Cleansing Notice - Issue of Securities
|
29 Aug 2024 10:02AM |
$0.035 |
$0.019 |
fallen by
45.71%
|
|
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
FY24 Full Year Results - Investor Presentation
|
29 Aug 2024 10:02AM |
$0.060 |
$0.015 |
fallen by
75%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux is a leader in the development of topically applied prescription pharmaceutical products.
- The company has a 25+ year track record with US NDA, US ANDA, and EMA product approvals.
- Acrux has a network of CDMO for development, scale-up, and commercial manufacturing.
- The company has commercial licensees in over 40 countries.
- Acrux focuses on an underserved market segment in the United States.
- As of the presentation, Acrux has 7 topical prescription products under development.
- Dapsone 5% Gel and Prilocaine/Lidocaine Cream were recently launched in the United States.
- Acrux aims to develop a diversified, on-market portfolio of products generating sustainable revenue streams.
- The company has expertise in regulatory submissions and commercial product launches.
- FDA approval of 5 products since 2021 with 2 recent launches in the United States.
- Market size for topically applied drugs in the US is approximately $16bn.
- Acrux has a TGA approved GMP facility and specialized scientists for development and regulatory submission.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paterson Resources Ltd (PSL) ORDINARY FULLY PAID |
Materials |
$10 |
Completion of the sale of the Burraga Project, NSW
|
29 Aug 2024 10:02AM |
$0.022 |
$0.023 |
risen by
4.55%
|
|
PSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Paterson Resources Limited (ASX: PSL) completed the sale of its Burraga Project to Octo Mining Burraga Pty Ltd.
- The sale included the 100% issued capital of Paterson's subsidiaries: Burraga Copper Pty Ltd, BC Exploration Pty Ltd, and Old Lloyds Mine Pty Ltd.
- The Burraga Project consists of several exploration licenses and a land parcel in NSW.
- All conditions precedent under the share sale agreement have been satisfied.
- Paterson received A$2,650,000 in addition to a A$200,000 deposit.
- The sale provides additional funding for Paterson's flagship Grace Gold-Copper Project in the Paterson Province.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Air New Zealand Limited (AIZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$1,735 |
Dividend/Distribution - AIZ
|
29 Aug 2024 10:01AM |
$0.505 |
$0.525 |
risen by
3.96%
|
|
| Johns Lyng Group Limited (JLG) ORDINARY FULLY PAID |
Industrials |
$1,106 |
Change in Director's Interest Notice - Larisa Moran
|
29 Aug 2024 10:01AM |
$3.660 |
$3.900 |
risen by
6.56%
|
|
| Simble Solutions Limited (SIS) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appendix 4D and 1H24 Financial Report
|
29 Aug 2024 10:01AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
SIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Simble Solutions grew customers, ARR, and revenues in 2023.
- The company announced a capital raise of $511,700 with the issue of ordinary shares on 21 February 2024.
- Significant changes include the appointment of Steve Thornhill as Non-Executive Chair and the resignation of Ben Loiterton.
- The company started sales activities in China and Singapore, targeting major industrial organizations.
- Hall Chadwick NSW was appointed as the new auditor effective 12 June 2024.
- No dividends were paid, recommended, or declared during the financial half-year.
- The company reported revenue of $758,400 for the half-year ended 30 June 2024.
- Net cash used in operating activities decreased by 44.6% compared to the prior period.
- The company raised additional unsecured debt funding of $200,000 on 28 August 2024.
- Simble Solutions' financial performance is subject to macroeconomic risks, privacy, data breaches, cybersecurity, and competitive market risks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$282 |
FY24 Media Release
|
29 Aug 2024 10:01AM |
$1.265 |
$1.400 |
risen by
10.67%
|
|
GVF - Price-sensitive ASX Announcement
Full Release
Key Points
- GVF reports an operating profit before tax of $28.5 million for the year ended 30 June 2024.
- The company declares a fully franked final dividend of 3.3 cents per share.
- GVF's adjusted pre-tax NTA increased by 14.0% over FY2024.
- Shareholder total returns for the period were 18.1%.
- GVF's discount capture strategy generated 74% of the return over the period.
- The company anticipates similar dividend payouts for FY2025, subject to profit reserves.
- GVF’s portfolio is widely diversified with significant exposure to equity and debt markets.
- The investment strategy focuses on purchasing securities at a discount to their intrinsic value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 4G and Corporate Governance Statement FY24
|
29 Aug 2024 10:00AM |
$0.060 |
$0.015 |
fallen by
75%
|
|
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$5 |
Appendix 4E and Annual Report
|
29 Aug 2024 10:00AM |
$0.096 |
$0.069 |
fallen by
28.13%
|
|
AER - Price-sensitive ASX Announcement
Full Release
Key Points
- Aeeris Ltd achieved significant growth and strategic execution in FY24.
- The company maintained a strong cash position with zero debt as of 30 June 2024.
- Established new strategic partnerships with Tomorrow.io and Weatherwatch.
- Expanded its Climatics platform into New Zealand.
- Climatics platform underwent significant enhancements for better climate risk analysis.
- Customer retention rate was at 97% with 38 new customers onboarded.
- Major contract renewals, including a five-year agreement with a large Australian insurance provider.
- Focus on innovation and AI-driven advancements to maintain leadership in weather climate services.
- Continued investment in technology and infrastructure to enhance product offerings.
- Committed to delivering long-term value for shareholders and maintaining robust governance practices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$98 |
Proposed issue of securities - VR1
|
29 Aug 2024 9:59AM |
$0.013 |
$0.054 |
risen by
315.38%
|
|
| Dundas Minerals Limited (DUN) ORDINARY FULLY PAID |
Materials |
$2 |
Application for quotation of securities - DUN
|
29 Aug 2024 9:59AM |
$0.035 |
$0.019 |
fallen by
45.71%
|
|
| Vection Technologies Ltd (VR1) ORDINARY FULLY PAID |
Information Technology |
$98 |
Generative AI Company Acquisition
|
29 Aug 2024 9:59AM |
$0.013 |
$0.054 |
risen by
315.38%
|
|
VR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Vection Technologies Ltd to acquire The Digital Box S.p.A., a generative AI company.
- The acquisition aims to enhance Vection’s AI and XR capabilities.
- The Digital Box reported $10 million in revenue and $1 million EBITDA for FY24.
- Former Apple COO Marco Landi will join Vection’s board as non-executive chair.
- The acquisition includes an equity raising of $2 million to support the acquisition and working capital.
- TDB’s technology enables voice interaction with data, services, and information systems via advanced natural language processing.
- The acquisition's initial enterprise value is approximately $12 million.
- Settlement expected in Q2 FY25, subject to customary closing conditions.
- Integration of TDB’s technology is expected to open new growth opportunities for both companies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 4E and FY24 Full Year Statutory Accounts
|
29 Aug 2024 9:59AM |
$0.060 |
$0.015 |
fallen by
75%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux reported a 32% decline in total revenue to $8,098,000.
- Net loss for the period attributable to members increased by 92% to ($5,800,000).
- No dividends were declared or paid for the year ending June 30, 2024.
- Nitroglycerin 0.4% Ointment ANDA was accepted by the FDA for review.
- Dapsone 5% Gel was launched in the US in April 2024.
- Dapsone 7.5% Gel was approved by the FDA in August 2024, planned for FY25 launch.
- Testosterone Topical Solution ANDA was divested.
- Acrux received $2.869 million for FY23 R&D Tax Incentive and $1.487 million for FY24
- Cash and cash equivalents on hand at year end totaled $2.945 million, down $3.287 million from prior year.
- Acrux's product pipeline consists of 15 products at various stages of development and commercialization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Panoramic Resources Limited (PAN) ORDINARY FULLY PAID |
Materials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2024 9:58AM |
$0.035 |
$0.035 |
fallen by
0%
|
|
| Nightingale Intelligent Systems, Inc (NGL) ORDINARY FULLY PAID |
Industrials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2024 9:58AM |
$0.043 |
$0.043 |
fallen by
0%
|
|
| Asaplus Resources Limited (AJY) ORDINARY FULLY PAID |
Materials |
- |
Removal from Official List - Annual Listing Fees
|
29 Aug 2024 9:58AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
